• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于经导管栓塞的生物可吸收水凝胶微球:制备和体外评价。

Bioresorbable hydrogel microspheres for transcatheter embolization: preparation and in vitro evaluation.

机构信息

Department of Radiology, University of Minnesota, Minneapolis, MN 55455, USA.

出版信息

J Vasc Interv Radiol. 2011 Oct;22(10):1464-1470.e2. doi: 10.1016/j.jvir.2011.06.010. Epub 2011 Aug 4.

DOI:10.1016/j.jvir.2011.06.010
PMID:21816624
Abstract

PURPOSE

To develop and evaluate a bioresorbable spherical material for embolization.

MATERIALS AND METHODS

New bioresorbable hydrogel microspheres were prepared from carboxymethyl cellulose and chitosan by using an inverse emulsion method. Size distribution of the microspheres was determined with a microscope, and the colorability was tested with Evans blue dye. The compressibility was examined with a texture analyzer. After sieving, the suspendability of the microspheres was tested in saline solution/contrast agent mixture in different ratios, and then the injectability was tested with microcatheters (lumen sizes of 0.0165, 0.019, and 0.027 inches). The in vitro degradability tests were performed in a lysozyme solution. Cell culture study of the microspheres was performed with human fibroblasts.

RESULTS

The microspheres exhibit diameters of 100-1,550 μm with a transparent appearance. Their fracture force can reach 0.58-0.88 N, and fracture deformation varies from approximately 70% to 95% of their original size. These microspheres can be colored by Evans blue dye, and uniform subgroups of microspheres can be readily obtained by sieving. Within 3 minutes, the microspheres form a stable suspension in a 4:6 contrast agent/saline solution mixture, which can be easily injected through microcatheters without aggregating or clogging. These microspheres are biodegradable, with degradation times varying from 2 weeks to 1 month, depending on their composition. Cell culture studies reveal no adverse effect on the growth of human fibroblasts in the presence of the microspheres.

CONCLUSIONS

A biodegradable and noncytotoxic microsphere was successfully prepared. It can be well suspended in the contrast solution and easily injected through a microcatheter.

摘要

目的

开发并评估一种可生物吸收的球形栓塞材料。

材料和方法

采用反相乳液法,由羧甲基纤维素和壳聚糖制备新型可生物吸收的水凝胶微球。使用显微镜测定微球的粒径分布,用 Evans 蓝染料测试其着色性。用质构仪测定压缩性。筛分后,在不同比例的盐溶液/对比剂混合物中测试微球的悬浮性,然后用微导管(内径分别为 0.0165、0.019 和 0.027 英寸)测试可注射性。在溶菌酶溶液中进行体外降解试验。用人成纤维细胞进行微球的细胞培养研究。

结果

微球呈透明外观,粒径为 100-1550μm。其断裂力可达 0.58-0.88N,断裂变形约为原始尺寸的 70%-95%。这些微球可以用 Evans 蓝染料着色,通过筛分可以很容易地获得均匀的微球亚群。在 3 分钟内,微球在 4:6 的对比剂/盐溶液混合物中形成稳定的悬浮液,可轻松通过微导管注入,不会聚集或堵塞。这些微球具有可降解性,降解时间取决于其组成,从 2 周到 1 个月不等。细胞培养研究表明,微球存在时对人成纤维细胞的生长没有不良影响。

结论

成功制备了一种可生物降解且无细胞毒性的微球。它可以很好地悬浮在对比溶液中,并通过微导管轻松注射。

相似文献

1
Bioresorbable hydrogel microspheres for transcatheter embolization: preparation and in vitro evaluation.用于经导管栓塞的生物可吸收水凝胶微球:制备和体外评价。
J Vasc Interv Radiol. 2011 Oct;22(10):1464-1470.e2. doi: 10.1016/j.jvir.2011.06.010. Epub 2011 Aug 4.
2
Doxorubicin loading and eluting characteristics of bioresorbable hydrogel microspheres: in vitro study.载药和洗脱特性的阿霉素生物可吸收水凝胶微球:体外研究。
Int J Pharm. 2011 May 16;409(1-2):185-93. doi: 10.1016/j.ijpharm.2011.02.058. Epub 2011 Mar 4.
3
An in situ forming biodegradable hydrogel-based embolic agent for interventional therapies.一种用于介入治疗的原位形成可生物降解水凝胶栓塞剂。
Acta Biomater. 2013 Sep;9(9):8182-91. doi: 10.1016/j.actbio.2013.06.020. Epub 2013 Jun 19.
4
In vitro and in vivo evaluation of chitosan microspheres with different deacetylation degree as potential embolic agent.不同脱乙酰度壳聚糖微球作为潜在栓塞剂的体内外评价。
Carbohydr Polym. 2014 Nov 26;113:304-13. doi: 10.1016/j.carbpol.2014.06.080. Epub 2014 Jul 11.
5
In vitro and in vivo evaluation of biodegradable embolic microspheres with tunable anticancer drug release.可生物降解栓塞微球的体外和体内评估及其可调节的抗癌药物释放。
Acta Biomater. 2013 Jun;9(6):6823-33. doi: 10.1016/j.actbio.2013.02.017. Epub 2013 Feb 16.
6
In vitro comparative study of drug loading and delivery properties of bioresorbable microspheres and LC bead.生物可吸收微球与LC微珠载药及释药特性的体外比较研究
J Mater Sci Mater Med. 2016 Dec;27(12):174. doi: 10.1007/s10856-016-5786-2. Epub 2016 Oct 17.
7
[Preparation of basic fibroblast growth factor chitosan microsphere and its properties].碱性成纤维细胞生长因子壳聚糖微球的制备及其性质
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012 Aug;26(8):989-92.
8
Trisacryl gelatin microspheres for therapeutic embolization, I: development and in vitro evaluation.用于治疗性栓塞的三丙烯酸明胶微球,I:研制与体外评价
AJNR Am J Neuroradiol. 1996 Mar;17(3):533-40.
9
Uniform biodegradable hydrogel microspheres fabricated by a surfactant-free electric-field-assisted method.通过无表面活性剂电场辅助法制备的均匀可生物降解水凝胶微球。
Macromol Biosci. 2007 Apr 10;7(4):423-8. doi: 10.1002/mabi.200700020.
10
Highly spherical and deformable chitosan microspheres for arterial embolization.用于动脉栓塞的高度球形且可变形的壳聚糖微球。
Chem Pharm Bull (Tokyo). 2010 Mar;58(3):288-92. doi: 10.1248/cpb.58.288.

引用本文的文献

1
Advanced targeted microsphere embolization for arteriovenous malformations: state-of-the-art and future directions.用于动静脉畸形的先进靶向微球栓塞术:现状与未来方向。
Neuroradiology. 2025 Apr;67(4):1009-1022. doi: 10.1007/s00234-025-03584-3. Epub 2025 Mar 15.
2
Preparation and Properties of Sodium Carboxymethyl Cellulose Microspheres by Dropping Method.滴制法制备羧甲基纤维素钠微球及其性能研究
ACS Omega. 2025 Jan 30;10(5):4754-4762. doi: 10.1021/acsomega.4c09736. eCollection 2025 Feb 11.
3
Enhancement of treatment efficacy of hepatic tumours using Trans-arterial-chemoembolization.
经动脉化疗栓塞术提高肝肿瘤治疗效果
Am J Cancer Res. 2023 May 15;13(5):1623-1639. eCollection 2023.
4
Advances in Biomaterials and Technologies for Vascular Embolization.生物材料和血管栓塞技术的进展。
Adv Mater. 2019 Aug;31(33):e1901071. doi: 10.1002/adma.201901071. Epub 2019 Jun 6.
5
Biopolymeric In Situ Hydrogels for Tissue Engineering and Bioimaging Applications.用于组织工程和生物成像应用的生物聚合物原位水凝胶
Tissue Eng Regen Med. 2018 Sep 14;15(5):575-590. doi: 10.1007/s13770-018-0159-1. eCollection 2018 Oct.
6
Advances in Degradable Embolic Microspheres: A State of the Art Review.可降解栓塞微球的研究进展:现状综述
J Funct Biomater. 2018 Jan 26;9(1):14. doi: 10.3390/jfb9010014.
7
In vitro comparative study of drug loading and delivery properties of bioresorbable microspheres and LC bead.生物可吸收微球与LC微珠载药及释药特性的体外比较研究
J Mater Sci Mater Med. 2016 Dec;27(12):174. doi: 10.1007/s10856-016-5786-2. Epub 2016 Oct 17.
8
Calibrated Bioresorbable Microspheres as an Embolic Agent: An Experimental Study in a Rabbit Renal Model.校准后的可生物吸收微球作为一种栓塞剂:在兔肾模型中的实验研究
J Vasc Interv Radiol. 2015 Dec;26(12):1887-94.e1. doi: 10.1016/j.jvir.2015.01.014. Epub 2015 Mar 29.
9
Endometrial stromal sarcoma with selective polyvinyl alcohol embolization of a pulmonary metastasis after recurrent hemoptysis and expansive growth.复发性咯血及肿瘤生长后,对肺转移灶行选择性聚乙烯醇栓塞治疗的子宫内膜间质肉瘤
Rare Tumors. 2010 Jun 30;2(2):e29. doi: 10.4081/rt.2010.e29.